MES V 180 (Pyridostigmine Bromide Extended-Release 180 mg)
Pill with imprint MES V 180 is Yellow, Capsule-shape and has been identified as Pyridostigmine Bromide Extended-Release 180 mg. It is supplied by Oceanside Pharmaceuticals.
Pyridostigmine is used in the treatment of myasthenia gravis; reversal of nondepolarizing muscle relaxants; nerve agent pretreatment and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MES V 180
Pyridostigmine Bromide Extended-Release
- Imprint
- MES V 180
- Strength
- 180 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinergic muscle stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Oceanside Pharmaceuticals
- Inactive Ingredients
-
carnauba wax,
zein,
magnesium stearate,
silicon dioxide,
tricalcium phosphate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68682-0301 | Oceanside Pharmaceuticals, Inc. |
| 00187-3013 | Bausch Health Companies Inc. |
Related images for "MES V 180"
More about pyridostigmine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (41)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: cholinergic muscle stimulants
Patient resources
- Drug Information
- Pyridostigmine Extended-Release Tablets
- Pyridostigmine Injection
- Pyridostigmine Liquid
- Pyridostigmine Tablets
- Other brands
- Mestinon, Mestinon Timespan, Regonol
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.